You are here

$5.55 Bn Transplant Diagnostics Market by Technology, Product, Application, Type, End-user and Region - Forecast to 2025

DUBLIN, Feb. 12, 2020 /PRNewswire/ -- The "Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global transplant diagnostics market is projected to reach USD 5.55 billion by 2025 from USD 3.66 billion in 2019, at a CAGR of 7.2%.

The demand for transplant diagnostic products is expected to grow due to technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities. The transplant diagnostics market is segmented on product, technology, application, transplant type, end user, and region.

The independent reference laboratories segment accounted for the largest share of the transplant diagnostics market, by end user, in 2019.

Based on end user, the transplant diagnostics market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the transplant diagnostics market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019.

The transplant diagnostics market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.

North America accounted for the largest share of the transplant diagnostics market in 2019.

North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.

Some of the prominent players in the transplant diagnostics market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Immucor, Inc. (US), bioMerieux (France), Becton, Dickinson and Company (US), and Omixon (Hungary).

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Transplant Diagnostics Market Overview
4.2 Market, By Technology
4.3 Regional Analysis: Market, By Application
4.4 Asia Pacific: Market, By End-user, 2019
4.5 Regional Analysis: Market, By Product & Service
4.6 Regional Analysis: Market, By Transplant Type
4.7 Market, By Country

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Increasing Number of Transplant Procedures
5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics
5.2.1.3 Increasing Public-Private Funding for Target Research Activities
5.2.1.4 Increasing Prevalence of Infectious Diseases
5.2.2 Key Market Restraints
5.2.2.1 High Procedural Cost of Ngs- and Pcr-Based Diagnostic Assays
5.2.2.2 Limited Reimbursements for Target Procedures
5.2.3 Key Market Opportunities
5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation
5.2.3.2 Growing Public Awareness About Organ Donation and Transplantation
5.2.4 Key Market Challenges
5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually
5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Technology
6.1 Introduction
6.2 Molecular Assay Technologies
6.2.1 Pcr-Based Molecular Assays
6.2.1.1 Sequence-Specific Oligonucleotide-Pcr
6.2.1.1.1 Sso-Pcr is the Most Widely Adopted Technique in the Pcr-Based Molecular Assays Market
6.2.1.2 Sequence-Specific Primer-Pcr
6.2.1.2.1 Growing Public-Private Investments for Research Activities to Support Market Growth
6.2.1.3 Real-Time Pcr
6.2.1.3.1 Real-Time Pcr Requires Smaller Sample Volumes As Compared to Conventional Pcr Technologies
6.2.1.4 Other Pcr-Based Molecular Assays
6.2.2 Sequencing-Based Molecular Assays
6.2.2.1 Sanger Sequencing
6.2.2.1.1 Sanger Sequencing Segment to Register the Highest Growth in the Sequencing-Based Molecular Assays Market
6.2.2.2 Next-Generation Sequencing
6.2.2.2.1 Low Turnaround Time & High Throughput Sequencing are the Major Factors Supporting the Adoption of Ngs
6.2.2.3 Other Sequencing-Based Molecular Assays
6.3 Non-Molecular Assay Technologies
6.3.1 Replacement of Non-Molecular Assay Techniques With Dna-Based Techniques is Expected to Hamper Market Growth

7 Transplant Diagnostics Market, By Product & Service
7.1 Introduction
7.2 Reagents & Consumables
7.2.1 Reagents & Consumables - the Largest & Fastest-Growing Segment in the Market
7.3 Instruments
7.3.1 Increasing Public-Private Investments Will Support Market Growth
7.4 Software & Services
7.4.1 Growing Automation & Digitalization of Diagnostic Laboratory Procedures are Supporting Market Growth

8 Transplant Diagnostics Market, By Application
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Pre-Transplantation Diagnostics
8.2.1.1 Infectious Disease Testing
8.2.1.1.1 Growing Adoption of Advanced Molecular Techniques for Pathogen Detection to Drive Market Growth
8.2.1.2 Histocompatibility Testing
8.2.1.2.1 Technological Advancements and Growing R&D Activities Indicate Strong Growth Potential in This Segment
8.2.1.3 Blood Profiling
8.2.1.3.1 Growing Availability of Molecular Assay Products has Supported Market Growth
8.2.2 Post-Transplantation Diagnostics
8.2.2.1 Greater Risk of Disorders & Infections Post-Transplantation Makes Diagnostics A Necessary Step
8.3 Research Applications
8.3.1 Growing Funding for Research has Driven Market Growth

9 Transplant Diagnostics Market, By Transplant Type
9.1 Introduction
9.2 Solid Organ Transplantation
9.2.1 Kidney Transplantation
9.2.1.1 Market Growth is Mainly Driven By Rising Kidney Disease Prevalence
9.2.2 Liver Transplantation
9.2.2.1 Growing Patient Population With Chronic Liver Diseases and Increasing Procedural Volume are the Key Indicators of Market Growth
9.2.3 Lung Transplantation
9.2.3.1 Rising Prevalence of Chronic Lung Disease is A Key Growth Driver of This Market Segment
9.2.4 Heart Transplantation
9.2.4.1 Rising Procedural Volume Indicates Strong Growth Prospects
9.2.5 Pancreas Transplantation
9.2.5.1 Procedural Complexity and the Risk of Surgical Complications Have Restrained the Demand for Market Products in This Segment
9.2.6 Other Organ Transplantations
9.3 Stem Cell Transplantation
9.3.1 Rising Procedural Volume and Growing Research Activities are Driving the Growth of the Market
9.4 Soft Tissue Transplantation
9.4.1 Technological Advancements and Rising Prevalence of Target Diseases Have Driven Market Growth
9.5 Bone Marrow Transplantation
9.5.1 Dearth of Well-Trained Surgeons to Perform Bone Marrow Transplantation is Expected to Hinder Market Growth

10 Transplant Diagnostics Market, By End User
10.1 Introduction
10.2 Independent Reference Laboratories
10.2.1 Rising Consolidation of Diagnostic Laboratories to Drive Market Growth
10.3 Hospitals & Transplant Centers
10.3.1 Growing Purchasing Power of Hospitals & Transplant Centers has Resulted in High Market Growth
10.4 Research Laboratories & Academic Institutes
10.4.1 Growing Awareness About the Genetic Techniques in Transplant Rejection Monitoring to Drive Market Growth

11 Transplant Diagnostics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 Ongoing Technological Advancements in the Field of Transplant Diagnostics to Drive Market Growth in the US
11.2.2 Canada
11.2.2.1 Growing Availability of Transplant Diagnostic Products to Support Market Growth in Canada
11.3 Europe
11.3.1 Germany
11.3.1.1 Germany Accounted for the Largest Share of the European Market
11.3.2 UK
11.3.2.1 Rising Number of Transplantation Procedures to Drive Market Growth in the UK
11.3.3 France
11.3.3.1 Adoption of Molecular Diagnostic Techniques for Donor-Recipient Compatibility Testing is Increasing in France
11.3.4 Spain
11.3.4.1 Rising Number of Solid Organ Transplantation Procedures to Drive Market Growth in Spain
11.3.5 Italy
11.3.5.1 Sluggish Growth in the Italian Healthcare Sector in the Last Few Years to Restrain Market Growth
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.1.1 Healthcare Infrastructural Improvements to Support Market Growth in China
11.4.2 India
11.4.2.1 Increasing Number of Transplantation Procedures to Drive Market Growth in India
11.4.3 Japan
11.4.3.1 Significant Growth in Chronic Disease Prevalence to Support Market Growth in Japan
11.4.4 Australia
11.4.4.1 Rising Number of Solid Organ Transplantation Procedures to Support Market Growth in Australia
11.4.5 South Korea
11.4.5.1 Government Initiatives to Introduce Medical Coverage for Transplantation to Support Market Growth in South Korea
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.1.1 Brazil Accounted for the Largest Share of the Latam Market
11.5.2 Mexico
11.5.2.1 Rising Medical Tourism to Support Market Growth in Mexico
11.5.3 Rest of Latam
11.6 Middle East & Africa

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Scenario
12.3.1 Product Launches & Enhancements
12.3.2 Agreements, Partnerships, and Collaborations
12.3.3 Acquisitions
12.3.4 Expansions
12.4 Competitive Leadership Mapping
12.4.1 Visionary Leaders
12.4.2 Innovators
12.4.3 Dynamic Differentiators
12.4.4 Emerging Companies

13 Company Profiles
13.1 Becton, Dickinson and Company
13.2 Biofortuna
13.3 bioMerieux S.A.
13.4 Bio-Rad Laboratories
13.5 Caredx
13.6 F. Hoffman-La Roche Limited
13.7 Gendx
13.8 Hologic, Inc.
13.9 Illumina, Inc.
13.10 Immucor, Inc.
13.11 Luminex Corporation
13.12 Merck KGaA
13.13 Omixon
13.14 Qiagen N.V.
13.15 Thermo Fisher Scientific
13.16 Emerging Players
13.16.1 Alpha Biotech, Ltd.
13.16.2 Bag Healthcare
13.16.3 Hansa Biopharma AB
13.16.4 Histogenetics LLC
13.16.5 Pacific Biosciences of California, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/lk40uo

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/5-55-bn-transplant-diagnostics-market-by-technology-product-application-type-end-user-and-region---forecast-to-2025--301003707.html

SOURCE Research and Markets